Akcea and Ionis Receive Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen)

    NEXT STORY
    Paratek Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference
    PREV STORY
    Mithra Reports 2018 Annual Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Marinus Pharmaceuticals Completes Patient Recruitment in Phase 3 Clinical Trial of Ganaxolone in Focal Onset Seizures

    RADNOR, Pa., Dec. 16, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Karyopharm Announces Phase 1b Selinexor Sarcoma Data Published in Journal of Clinical Oncology

    Data Provide Early Evidence of Anticancer Activity in Advanced Sarcoma and Inform Recommended Phase ...

    author_avatar
    NASDAQ Market News

    The Global Rapid Diagnostics Market is expected to grow from USD 18,236.13 Million in 2018 to USD 38,256.52 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 11.16%

    author_avatar
    NASDAQ Market News